Keywords
Penile implant, penile glans enhancement, penile venous stripping, prosthesis extrusion, soft glans syndrome, shrinkage glans penis
INTRODUCTION
In 1998, the first agent of PDE-5 inhibitor was available to treat patients who have erectile dysfunction regardless of varied underlying causes (ED).1 Subsequently, this type of agent opened the era of medical treatment as the first line of options for these awkward diseases.2,3 The second-line varied treatment strategy will be resorted if patients are poorly responsive to the oral PDE-5 inhibitors.4 These second-line options include vacuum constriction devices, vasodilator intracorporeal injection, endovascular therapies entailing sclerotherapy, and controversial penile vascular surgery.5 Although no sustainable scientific support exists, resulting in none that the Federal Drug Administration has proved in the United States, recent popularity has soared among marketers. There are many, such as extracorporeal shock wave therapy (ESWT) supported by randomized studies,6 platelet-rich plasma (PRP) injection, stem cell injection, etc. Still, the penile implant remains a golden solution for those patients whose erection dysfunction has been refractory.7
Some complications in this golden standard option appear unavoidable, such as shrined soft glans syndrome, mechanical failure, intracorporeal infection, and prosthesis extrusion, which is the most hazardous.8 These issues might suffer psychologically, but not just physically, for patients who underwent a prior penile implant, particularly the most typical issue of soft glans syndrome complained about by their sexual partner. We report an example case of suffering from soft glans syndrome with impending prosthesis loss in his sixth journey of penile implantation. However, he is unaware of an imminent prosthesis loss on the patient’s side. Given appropriate housing, a penile implant was published in 1994;9 this surgery niche has not been popularly recognized in the urology profession; we sought to report this case in solving the shrinkage soft glans syndrome and implant malposition with a novel enhancement strategy,10 in addition to repositioning the implant on an ambulatory basis.